3Coleman RE. Metastatic bone disease : clinical features, pathophysiology and treatment strategies [ J]. Cancer Treat Rev, 2001,27 (3) :165-176.
4Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma[ J]. Cancer, 2000,88 ( 12 Suppl) :2989-2994.
5Pardali K, Moustakas A. Actions of TGF-β as tumor suppressor andpro-metastatic factor in human cancer [ J ]. Biochim Biophys Acta, 2007,1775 ( 1 ) :21-62.
6Pasche B. Role of transforming growth factor beta in cancer[ J]. J Cell Physiol, 2001,186(2) :153-168.
7Kaminska B, Wesolowska A, Danilkiewicz M. TGF beta signalling and its role in tumour pathogenesis [ J]. Acta Biochim Pol, 2005,52 (2) :329-337.
8Zhu B, Kyprianou N. Transforming growth factor beta and prostate cancer[ J]. Cancer Treat Res, 2005,126 ( 1 ) : 157-173.
9Buijs J'F, Henriquez NV, van Overveld PG, et al. TGF-beta and BMP interactions in tumour progression and bone metastasis [ J ]. Clin Exp Metastasis, 2007,24(8) :609-617.
